Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AJ
- Chemical substanceJ05AJ03Dolutegravir
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 23 medicines
- Tivicay10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 50MG BASE · tablet · Viiv Hlthcare
- Tivicay PD5MG BASE · tablet, for suspension · Viiv Hlthcare
- Dolutegravir10MG, 5MG · film · Laurus Generics INC
- Dovato50MG BASE; 300MG · tablet · Viiv Hlthcare
Brazil
Anvisa · 11 medicines



